SEC filings

Lucid Diligence Brief - BioPharma

Rallybio Avenzo Merger and $215M Financing | Lucid Diligence Brief

Rallybio and Avenzo’s reverse merger puts Nasdaq access, $215M financing and…

by Pankaj Rathod

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular Collaboration

Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027

Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027 Professional…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.